Business / Finance

RSS

BrainStorm Cell Therapeutics reports financial results for Q1 2015, provides business update

BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced financial results and provided a business update for the first quarter ended March 31, 2015.

14 May 2015

LABINDIA to promote Dotmatics’ scientific informatics solutions, services in India

Dotmatics, the leading provider of scientific informatics solutions and services for the pharma, biotech, chemicals, agrochemicals and academia announced today that it has appointed LABINDIA as a distributor in India.

14 May 2015

Save the date: MEDICA and COMPAMED from 16 – 19 November 2015

Planning is already running at full blast for the MEDICA 2015 and COMPAMED 2015 being held in parallel...

13 May 2015

Galmed reports net loss of $2.5 million for first quarter 2015

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral therapy for the treatment of liver diseases, today announced financial results for the three months ended March 31, 2015.

13 May 2015

Soligenix, Emergent BioSolutions sign development agreement

Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that it has initiated a development agreement with Emergent BioSolutions to implement a commercially viable, scalable production technology for the RiVax drug substance protein antigen.

13 May 2015

Lighthouse Instruments announces strategic business partnership with Robert Bosch

Lighthouse Instruments, LLC, a world leader in laser test and measurement systems for pharmaceutical process monitoring, today announced a strategic business partnership with Robert Bosch, GmbH to develop and distribute a new machine series for container closure integrity (CCI) testing using Lighthouse's laser headspace analysis (HSA) technology.

13 May 2015

MEDICA CONNECTED HEALTHCARE FORUM will continue being a programme highlight at the MEDICA IT area

After its widely acclaimed debut and high level of public appeal within the scope of the MEDICA 2014, the MEDICA CONNECTED HEALTHCARE FORUM is going to be continued this year and is going to remain an important highlight within the programme of the world’s largest medical trade fair, MEDICA, which most recently had around 4,800 exhibitors and almost 130,000 specialist visitors.

12 May 2015

COCIR launches annual 5th Edition of its eHealth Toolkit

COCIR has launched the newest edition of its eHealth Toolkit, subtitled ‘Integrated Care: Breaking the Silos’. This year’s toolkit focuses on the value of Integrated Care, the challenges in implementing it and how health ICT technologies and procurement possibilities can facilitate it.

12 May 2015

DKSH supports Pfizer’s expansion to Laos

DKSH Business Unit Healthcare, the leading partner for healthcare companies seeking to grow their businesses in Asia, has signed an agreement to provide marketing, sales, logistics, distribution, credit management and -collection services to Pfizer in Laos.

12 May 2015

Touchstone Medical announces launch of the Orchid, innovative new disposable gynaecology speculum

Touchstone Medical, a specialist supplier of medical products to the gynaecology healthcare sector, is pleased to announce the launch of the Orchid, an innovative new disposable gynaecology speculum to the UK market.

12 May 2015

Inoviem Scientific receives €545,000 from French public investment bank bpifrance

Inoviem Scientific, a Contract Research Biotech (CRB) company today announces that it has received additional funding of €545,000 ($611,000) from French public investment bank bpifrance. The company leverages two proprietary technologies to offer pharmaceutical players increased speed and enhanced safety at all stages of drug development; from drug discovery (the identification of secondary targets and detection of potential adverse effects, etc.) through to clinical trials (with patient stratification and identification of biomarkers, etc.).

12 May 2015

CPhI Istanbul 2015 opens as Turkey continues to dominate the MENA pharma region

Turkey is fast emerging as a new hub for pharma manufacturing. This year, CPhI Istanbul will welcome more than 200 exhibitors from 23 Countries and over 4,000 visitors..

12 May 2015

Perrigo announces acquisition of Patheon's Mexican operations for $34 million

Perrigo Company plc announced today that it has acquired the Mexican operations of Durham, North Carolina-based Patheon for $34 million in cash.

12 May 2015

Cardiome signs commercialization agreement with AOP for ESMOCARD products

Cardiome Pharma Corp. today announced that the company has entered a commercialization agreement with AOP Orphan Pharma to sell AOP's cardiovascular products, ESMOCARD and ESMOCARD LYO (esmolol hydrochloride) in Italy, France, Spain and Belgium.

12 May 2015

China Pharma revenue decreases 20% to $5.7 million in Q1 2015

China Pharma Holdings, Inc., an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the quarter ended March 31, 2015.

12 May 2015

GP out-of-hours reforms linked to more emergency admissions for children

A study published today in Annals of Family Medicine, funded by the National Institute for Health Research, found that the GP contract was associated with an eight per cent increase in short stay admissions for potentially avoidable chronic conditions...

12 May 2015

Going to the dentist just got a little less scary for U.S. children with autism

Going to the dentist might have just gotten a little less scary for the estimated 1 in 68 U.S. children with autism spectrum disorder as well as children with dental anxiety, thanks to new research from USC.

12 May 2015

JHL Biotech closes $45.6 million Series C round of financing

JHL Biotech, Inc., an emerging biopharmaceutical company, today announced that it has closed a Series C fundraising of $45.6 million, led by funds managed by a global renowned crossover fund with over US$1.6 trillion in AUM, with participation from existing investor Milestone Capital and new investors Sungent BioVenture and Liwick Investment Management.

12 May 2015

The Project Data Sphere® initiative achieves 1st year milestones

Cancer community broadly shares, integrates, and analyzes clinical trial data within a single research platform to advance innovation and improve lives...

11 May 2015

Debiotech agrees to acquire exclusive rights on iSense CGM technology for use with patch pumps

Debiotech of Switzerland and iSense CGM, Inc. of the US, announced today having entered into an Agreement under which Debiotech has the option to acquire the exclusive rights on the iSense CGM product and technology for use with patch pumps for diabetes therapy. Financial terms and conditions of the Agreement are not disclosed.

11 May 2015